Cargando…

Preferred product attributes of a multipurpose vaginal ring: Findings from a phase 1 trial

INTRODUCTION: Most women face multiple and co-occurring risks from unwanted pregnancy, human immunodeficiency virus (HIV) and other sexually transmitted infections (STIs) at some point during their lifetime. While a range of contraceptive methods exist and options for HIV prevention are increasing,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tolley, Elizabeth E., Hanif, Homaira, Thurman, Andrea, Brache, Vivian, Doncel, Gustavo F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Reproductive Health
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10097978/ https://www.ncbi.nlm.nih.gov/pubmed/37064825 http://dx.doi.org/10.3389/frph.2023.1148134

Ejemplares similares

Acceptability of a Long-Acting, Multipurpose Vaginal Ring: Findings from a Phase I Trial in the U.S. and Dominican Republic
por: Tolley, Elizabeth E., et al.
Publicado: (2022)

Participant experiences with a multipurpose vaginal ring for HIV and pregnancy prevention during a phase 1 clinical trial: learning from users to improve acceptability
por: Shapley-Quinn, Mary Kate, et al.
Publicado: (2023)

Intravaginal rings as delivery systems for microbicides and multipurpose prevention technologies
por: Thurman, Andrea Ries, et al.
Publicado: (2013)

Randomized, placebo controlled phase I trial of the safety, pharmacokinetics, pharmacodynamics and acceptability of a 90 day tenofovir plus levonorgestrel vaginal ring used continuously or cyclically in women: The CONRAD 138 study
por: Thurman, Andrea R., et al.
Publicado: (2022)

Commentary: Multipurpose prevention technologies—What about sexually transmitted infections?
por: Lu, Anjanique Mariquit Rosete, et al.
Publicado: (2023)

Randomized controlled phase IIa clinical trial of safety, pharmacokinetics and pharmacodynamics of tenofovir and tenofovir plus levonorgestrel releasing intravaginal rings used by women in Kenya
por: Mugo, Nelly R., et al.
Publicado: (2023)

Multipurpose Prevention Technologies: Opportunities and Challenges to Ensure Advancement of the Most Promising MPTs
por: Young Holt, Bethany, et al.
Publicado: (2021)

Optimizing the pipeline of multipurpose prevention technologies: opportunities across women's reproductive lifespans
por: Bershteyn, Anna, et al.
Publicado: (2023)

Turning the promise of multipurpose prevention technologies into a market reality: a commentary
por: Dam, Anita, et al.
Publicado: (2023)

Biomedical, socio-behavioral, and implementation science gaps in multipurpose prevention technology research
por: Cummins, James E., et al.
Publicado: (2023)

Strategic actions to advance multipurpose prevention technologies in low- and middle-income countries
por: Young Holt, Bethany, et al.
Publicado: (2023)

Synthesis of end-user research to inform future multipurpose prevention technologies in sub-Saharan Africa: a scoping review
por: Bhushan, Nivedita L., et al.
Publicado: (2023)

End-to-end approach to ensuring equitable access to multipurpose prevention technologies in low- and middle-income countries
por: Cameron, Anne-Isabelle, et al.
Publicado: (2023)

A phase I study to assess safety, pharmacokinetics, and pharmacodynamics of a vaginal insert containing tenofovir alafenamide and elvitegravir
por: Thurman, Andrea R., et al.
Publicado: (2023)

Multipurpose Prevention Technologies: Biomedical Tools to Prevent HIV-1, HSV-2, and Unintended Pregnancies
por: Thurman, Andrea Ries, et al.
Publicado: (2011)

Microarray patch for HIV prevention and as a multipurpose prevention technology to prevent HIV and unplanned pregnancy: an assessment of potential acceptability, usability, and programmatic fit in Kenya
por: Gachigua, Sammy Gakero, et al.
Publicado: (2023)

Postmenopausal Vaginal Microbiome and Microbiota
por: de Oliveira, Nayara Santos, et al.
Publicado: (2022)

Characterization of the Ovine Vaginal Microbiome and Inflammation Patterns as an Improved Testing Model of Human Vaginal Irritation
por: Pyles, Richard B., et al.
Publicado: (2021)

Potential biomarkers to predict return to fertility after discontinuation of female contraceptives—looking to the future
por: Cordova-Gomez, Amanda, et al.
Publicado: (2023)

Randomized, placebo controlled phase I trial of safety, pharmacokinetics, pharmacodynamics and acceptability of tenofovir and tenofovir plus levonorgestrel vaginal rings in women
por: Thurman, Andrea Ries, et al.
Publicado: (2018)

The Impact of Over-The-Counter Lactic Acid Containing Vaginal Gels on the Integrity and Inflammatory State of the Vaginal Epithelium in vitro
por: Tyssen, David, et al.
Publicado: (2022)

HIV Pre-exposure Prophylaxis Implant Stated Preferences and Priorities: Results of a Discrete Choice Experiment Among Women and Adolescent Girls in Gauteng Province, South Africa
por: Little, Kristen M., et al.
Publicado: (2022)

Altered Innate Immunity and Damaged Epithelial Integrity in Vaginal Microbial Dysbiosis
por: Cheu, Ryan K., et al.
Publicado: (2022)

Vaginal microbiota and mucosal pharmacokinetics of tenofovir in healthy women using tenofovir and tenofovir/levonorgestrel vaginal rings
por: Thurman, Andrea Ries, et al.
Publicado: (2019)

Considerations for Choosing Soluble Immune Markers to Determine Safety of Novel Vaginal Products
por: Happel, Anna-Ursula, et al.
Publicado: (2022)

Menstrual tampons and vaginal pessaries: regulation of intravaginal medical devices by the US FDA
por: Pollard, Colin M.
Publicado: (2023)

Monitoring Recently Acquired HIV Infections in Amsterdam, The Netherlands: The Attribution of Test Locations
por: Slurink, Isabel A. L., et al.
Publicado: (2021)

Role of short interpregnancy interval, birth mode, birth practices, and the postpartum vaginal microbiome in preterm birth
por: Odogwu, Nkechi Martina
Publicado: (2023)

OR33-5 Low Systemic Levels of Segesterone Acetate are Required to Inhibit Ovulation in Women
por: Archer, David, et al.
Publicado: (2019)

Pre-birth acquisition of personhood: Incremental accrual of attributes as the framework for individualization by serial and concurrently acting developmental factors
por: Hughes, Claude L., et al.
Publicado: (2023)

Development of Gram Stain Scoring System Based on Pro-Inflammatory Cytokines in the Sheep Model for Testing Toxicity of Vaginal Products
por: Vincent, Kathleen L., et al.
Publicado: (2021)

Which vaginal douching agent is the best choice before oocyte retrieval? A systematic review and network meta-analysis
por: Meng, Ying, et al.
Publicado: (2022)

Vaginal Microbiota and Mucosal Pharmacokinetics of Tenofovir in Healthy Women Using a 90-Day Tenofovir/Levonorgestrel Vaginal Ring
por: Thurman, Andrea R., et al.
Publicado: (2022)

Role of the human vaginal microbiota in the regulation of inflammation and sexually transmitted infection acquisition: Contribution of the non-human primate model to a better understanding?
por: Adapen, Cindy, et al.
Publicado: (2022)

Development of in vitro methods to model the impact of vaginal lactobacilli on Staphylococcus aureus biofilm formation on menstrual cups as well as validation of recommended cleaning directions
por: Friberg, Maria, et al.
Publicado: (2023)

Tenofovir vaginal film as a potential MPT product against HIV-1 and HSV-2 acquisition: formulation development and preclinical assessment in non-human primates
por: Patel, Sravan Kumar, et al.
Publicado: (2023)

Silicone elastomer formulations for improved performance of a multipurpose vaginal ring releasing dapivirine and levonorgestrel
por: Dallal Bashi, Yahya H., et al.
Publicado: (2021)

End-user research in support of long-acting systemic antiretroviral delivery systems: insights from qualitative research with providers and target users in South Africa
por: Brown, Morgan S., et al.
Publicado: (2022)

Luteal Phase in Assisted Reproductive Technology
por: Tesarik, Jan, et al.
Publicado: (2020)

Editorial: Luteal Phase Support for Assisted Reproduction
por: Friedler, Shevach, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h37dtgd0cv9mt1sobbavth28dv